Spotlight

Key Points This scoping review maps the earliest clinical signs of AL, ATTRwt, and ATTRv amyloidosis to improve early recognition and diagnosis.Distinct red…

AbstractBACKGROUND:Transthyretin amyloid cardiomyopathy (ATTR-CM) causes a restrictive cardiomyopathy resulting in heart failure (HF). Signaling pathways associated…

AbstractThe growing pressures of population expansion, resource depletion, and climate change are intensifying global challenges in health, food security, and…

Rare diseases tend to remain under-discussed, underfunded, and underdiagnosed. One such condition is Amyloidosis, a collection of rare and potentially fatal…

https://www.oneamyloidosisvoice.com/wp-content/uploads/2024/03/Full-Article-hATTR-Holistic-Care-Con…

July 11, 2023 | Cardiovascular Business For years, cardiac amyloidosis was a rare and often fatal disease that had no treatment, so it was not front and center in…

Hereditary transthyretin (hATTR) amyloidosis, also known as variant ATTR (ATTRv) amyloidosis, is a rare disease affecting about 50,000 people worldwide. It's caused…

Individuals suffering with rare diseases had very few therapeutic options 40 years ago. But that began to change with the stroke of a pen by then-President Ronald…

UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve damage caused by hereditary transthyretin amyloidosis, a rare…

AL amyloidosis is a life-threatening disease related to bone marrow cancer, multiple myeloma. It is caused when a person's antibody-producing white blood cells (i.e…